碩貝德(300322.SZ)擬向金融機構申請綜合授信額度不超3億元
格隆匯1月18日丨碩貝德(300322.SZ)公佈,公司於2021年1月18日召開的第四屆董事會第十三次臨時會議審議通過了《關於向金融機構申請綜合授信額度的議案》,具體情況如下:
為了滿足公司擴大生產經營規模的需要,並確保公司業務的正常開展,提高公司融資能力,公司擬向平安銀行惠州分行營業部申請總額不超過人民幣3億元、有效期為3年的綜合授信額度(即3年有效期內循環向金融機構申請授信),用於貸款(含併購貸款、項目貸款等)、開立銀行承兑匯票、商業承兑匯票貼現、票據池質押融資業務、開立信用證、貿易融資、進口押匯、出口押匯、開具保函等信貸業務。
在綜合授信額度內,可分多次循環使用。實際額度﹑授信品種及使用期限以金融機構審批的結果為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.